MediWound Ltd. (MDWD) income statement
MDWDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 2/30
$13.68+0.13 (+0.96%)
Close on Nov 17, 2026Market cap $175.59MP/E –Yield –
MediWound Ltd. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2025
- Gross margin
- 19.2%
- Operating margin
- -149.0%
- Net margin
- –
- Return on equity, FY2025
- –
Financial strength
- Current ratio
- 2.32
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 23.4%
Valuation
- P/E ratio
- –
- Price to sales
- 10.35
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?